Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ModivCare IncMODV · Entity 76927 | Director · CEO and President | February 08, 2022 | February 10, 2022 |
| Option Care Health, Inc.BIOS · Entity 4126 | Chief Executive Officer | May 16, 2019 | May 21, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ModivCare Inc
Report date February 08, 2022 · Filed February 10, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,248 |
Reported balance
After 2022-02-08 transaction · row 1
1 source rowRow 1 · 2022-02-08 · Grant · Acquired 9,170 · Balance 44,248 F1: Represents restricted stock units scheduled to vest as follows: (1) 3,057 shares will vest on February 8, 2023, (2) 3,056 shares will vest on February 8, 2024 and (3) 3,057 shares will vest on February 8, 2025, in each case, subject to the reporting person's continued employment. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $110.07 · Expires 2029-02-08 | Direct | 26,136 |
Reported balance
After 2022-02-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-02-08 · Grant · Acquired 26,136 · Balance 26,136 F2: Option becomes exercisable with respect to: (1) 8,712 shares on February 8, 2023, (2) 8,712 shares on February 8, 2024 and (3) 8,712 shares on February 8, 2025, in each case, subject to the reporting person's continued employment. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2025-02-08 | Direct | 18,340 |
Reported balance
After 2022-02-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-02-08 · Grant · Acquired 18,340 · Balance 18,340 F3: Represents the contingent right to receive a number of shares of issuer common stock determined by multiplying the number of performance units by a percentage from 50% to 200% that corresponds to specified share price thresholds measured by reference to a volume-weighted average price (VWAP) of the issuer's common stock over a specified period of trading days prior to the expiration date of the award, subject to the reporting person's continued employment. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units scheduled to vest as follows: (1) 3,057 shares will vest on February 8, 2023, (2) 3,056 shares will vest on February 8, 2024 and (3) 3,057 shares will vest on February 8, 2025, in each case, subject to the reporting person's continued employment.
F2: Option becomes exercisable with respect to: (1) 8,712 shares on February 8, 2023, (2) 8,712 shares on February 8, 2024 and (3) 8,712 shares on February 8, 2025, in each case, subject to the reporting person's continued employment.
F3: Represents the contingent right to receive a number of shares of issuer common stock determined by multiplying the number of performance units by a percentage from 50% to 200% that corresponds to specified share price thresholds measured by reference to a volume-weighted average price (VWAP) of the issuer's common stock over a specified period of trading days prior to the expiration date of the award, subject to the reporting person's continued employment.
Option Care Health, Inc.
Report date May 16, 2019 · Filed May 21, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.0001 Par ValueSEC Table I · non-derivative | Direct | 375,305 |
Ending reported balance
After 2019-05-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-05-16 · Exercise / conversion · Acquired 197,727 · Balance 438,039 F1: 197,727 Restricted Stock Units (RSUs) vested on the first anniversary of the original grant date (May 3, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 197,727 RSUs until May 16, 2019. F2: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Row 2 · 2019-05-16 · Disposition to issuer · Disposed 62,734 · Balance 375,305 F3: This transaction represents shares withheld by the Company for tax withholding on Mr. Greenleaf's settlement of the RSU award described in this Form 4 that was settled on May 16, 2019. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-05-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-05-16 · Exercise / conversion · Disposed 197,727 · Balance 0 F2: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F1: 197,727 Restricted Stock Units (RSUs) vested on the first anniversary of the original grant date (May 3, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 197,727 RSUs until May 16, 2019. F4: The Restricted Stock Units vest on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: 197,727 Restricted Stock Units (RSUs) vested on the first anniversary of the original grant date (May 3, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 197,727 RSUs until May 16, 2019.
F2: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.
F3: This transaction represents shares withheld by the Company for tax withholding on Mr. Greenleaf's settlement of the RSU award described in this Form 4 that was settled on May 16, 2019.
F4: The Restricted Stock Units vest on the first anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2022 Filed Feb 10, 2022 21:09 UTC | ModivCare Inc MODV · Entity 76927 | GrantPerformance Restricted Stock Units · Derivative | 18,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003048 · rdgdoc.xml · derivative · entry 3 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,340 Underlying: Common Stock · Not disclosed shares Expires 2025-02-08 F3 · derivative.exercise_price: Represents the contingent right to receive a number of shares of issuer common stock determined by multiplying the number of performance units by a percentage from 50% to 200% that corresponds to specified share price thresholds measured by reference to a volume-weighted average price (VWAP) of the issuer's common stock over a specified period of trading days prior to the expiration date of the award, subject to the reporting person's continued employment. F3 · derivative.exercise_date: Represents the contingent right to receive a number of shares of issuer common stock determined by multiplying the number of performance units by a percentage from 50% to 200% that corresponds to specified share price thresholds measured by reference to a volume-weighted average price (VWAP) of the issuer's common stock over a specified period of trading days prior to the expiration date of the award, subject to the reporting person's continued employment. F3 · derivative.underlying_shares: Represents the contingent right to receive a number of shares of issuer common stock determined by multiplying the number of performance units by a percentage from 50% to 200% that corresponds to specified share price thresholds measured by reference to a volume-weighted average price (VWAP) of the issuer's common stock over a specified period of trading days prior to the expiration date of the award, subject to the reporting person's continued employment. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 21:09 UTC | ModivCare Inc MODV · Entity 76927 | GrantEmployee Stock Option (Right to Buy) · Derivative | 26,136 | $0.00 Strike: $110.07 | $0.00 |
DisclosureSEC source: 0001437749-22-003048 · rdgdoc.xml · derivative · entry 2 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,136 Underlying: Common Stock · 26,136 shares Expires 2029-02-08 F2 · derivative.exercise_date: Option becomes exercisable with respect to: (1) 8,712 shares on February 8, 2023, (2) 8,712 shares on February 8, 2024 and (3) 8,712 shares on February 8, 2025, in each case, subject to the reporting person's continued employment. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 21:09 UTC | ModivCare Inc MODV · Entity 76927 | GrantCommon Stock | 9,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003048 · rdgdoc.xml · nonDerivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,248 F1 · shares: Represents restricted stock units scheduled to vest as follows: (1) 3,057 shares will vest on February 8, 2023, (2) 3,056 shares will vest on February 8, 2024 and (3) 3,057 shares will vest on February 8, 2025, in each case, subject to the reporting person's continued employment. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 15:23 UTC | ModivCare Inc MODV · Entity 76927 | PurchaseCommon Stock | 581 | $172.85 | $100,425.85 |
DisclosureSEC source: 0001437749-21-022319 · rdgdoc.xml · nonDerivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,078 Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 18:51 UTC | ModivCare Inc MODV · Entity 76927 | Tax withholdingCommon Stock | 1,179 | $178.53 | $210,486.87 |
DisclosureSEC source: 0001437749-21-003176 · rdgdoc.xml · nonDerivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,497 F1 · shares: Number of shares of common stock issuable upon vesting of previously reported RSU award withheld to satisfy the reporting person's related tax withholding obligations. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 17:09 UTC | ModivCare Inc MODV · Entity 76927 | GrantEmployee Stock Option (Right to Buy) · Derivative | 16,595 | $0.00 Strike: $179.24 | $0.00 |
DisclosureSEC source: 0001437749-21-002831 · rdgdoc.xml · derivative · entry 2 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,595 Underlying: Common Stock · 16,595 shares Expires 2026-02-10 F2 · derivative.exercise_date: This option will become fully exercisable as follows: (1) 5,532 options will vest on February 10, 2022, (2) 5,531 options will vest on February 10, 2023, and (3) 5,532 options will vest on February 10, 2024, in each case, subject to Mr. Greenleaf's continued employment. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 17:09 UTC | ModivCare Inc MODV · Entity 76927 | GrantCommon Stock | 4,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-002831 · rdgdoc.xml · nonDerivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,136 F1 · shares: Represents restricted stock units scheduled to vest as follows: (1) 1,581 shares will vest on February 10, 2022, (2) 1,580 shares will vest on February 10, 2023, and (3) 1,581 shares will vest on February 10, 2024, in each case, subject to Mr. Greenleaf's continued employment. Read SEC document |
| February 10, 2021 Filed Apr 12, 2021 16:30 UTC Amendment | ModivCare Inc MODV · Entity 76927 | GrantEmployee Stock Option (Right to Buy) · Derivative | 15,491 | $0.00 Strike: $179.24 | $0.00 |
DisclosureSEC source: 0001437749-21-008721 · rdgdoc.xml · derivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,491 Underlying: Common Stock · 15,491 shares Expires 2028-02-10 F1 · derivative.exercise_date: This option will become fully exercisable as follows: (1) 5,164 options will vest on February 10, 2022, (2) 5,163 options will vest on February 10, 2023, and (3) 5,164 options will vest on February 10, 2024, in each case, subject to Mr. Greenleaf's continued employment. Read SEC document |
| December 11, 2020 Filed Dec 15, 2020 13:31 UTC | ModivCare Inc PRSC · Entity 76927 | Tax withholdingCommon Stock | 1,457 | $142.97 | $208,307.29 |
DisclosureSEC source: 0001437749-20-025367 · rdgdoc.xml · nonDerivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,934 F1 · shares: Number of shares of common stock issuable upon vesting of previously reported RSU award withheld to satisfy the reporting person's related tax withholding obligations. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 16:21 UTC | ModivCare Inc PRSC · Entity 76927 | GrantStock Options (right to buy) · Derivative | 45,119 | $0.00 Strike: $69.18 | $0.00 |
DisclosureSEC source: 0001437749-20-002913 · rdgdoc.xml · derivative · entry 2 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,119 Underlying: Common Stock · 45,119 shares Expires 2027-02-13 F2 · derivative.exercise_date: Subject to the terms and conditions of the applicable award agreement, these options are scheduled to vest in equal installments as follows: 1/3rd on the first anniversary of the grant date, 1/3rd on the second anniversary of the grant date and 1/3rd on the third anniversary of the grant date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 16:21 UTC | ModivCare Inc PRSC · Entity 76927 | GrantCommon Stock | 12,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-002913 · rdgdoc.xml · nonDerivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,391 F1 · shares: Subject to the terms and conditions of the applicable award agreement, these restricted stock units are scheduled to vest in equal installments as follows: 1/3rd on the first anniversary of the grant date, 1/3rd on the second anniversary of the grant date and 1/3rd on the third anniversary of the grant date. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 18:13 UTC | ModivCare Inc PRSC · Entity 76927 | GrantStock Options (right to buy) · Derivative | 40,432 | $0.00 Strike: $68.14 | $0.00 |
DisclosureSEC source: 0001437749-19-024450 · rdgdoc.xml · derivative · entry 3 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,432 Underlying: Common Stock · 40,432 shares Expires 2026-12-11 F3 · derivative.exercise_date: Subject to the terms and conditions of the applicable award agreement, these "Premium Priced Options" are scheduled to vest in equal installments as follows: 25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, 25% on the third anniversary of the grant date and the remaining 25% on the fourth anniversary of the grant date Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 18:13 UTC | ModivCare Inc PRSC · Entity 76927 | GrantStock Options (right to buy) · Derivative | 67,090 | $0.00 Strike: $59.25 | $0.00 |
DisclosureSEC source: 0001437749-19-024450 · rdgdoc.xml · derivative · entry 2 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,090 Underlying: Common Stock · 67,090 shares Expires 2026-12-11 F2 · derivative.exercise_date: Subject to the terms and conditions of the applicable award agreement, these "Market Strike Options" are scheduled to vest in equal installments as follows: 25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, 25% on the third anniversary of the grant date and the remaining 25% on the fourth anniversary of the grant date. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 18:13 UTC | ModivCare Inc PRSC · Entity 76927 | GrantCommon Stock | 20,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-024450 · rdgdoc.xml · nonDerivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,104 F1 · shares: Subject to the terms and conditions of the applicable award agreement, these restricted stock units are scheduled to vest in equal installments as follows: 25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, 25% on the third anniversary of the grant date and the remaining 25% on the fourth anniversary of the grant date. Read SEC document |
| May 16, 2019 Filed May 21, 2019 00:12 UTC | Option Care Health, Inc. BIOS · Entity 4126 | Exercise / conversionRestricted Stock Unit · Derivative | 197,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-019235 · form4.xml · derivative · entry 3 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.0001 Par Value · 197,727 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F1 · date: 197,727 Restricted Stock Units (RSUs) vested on the first anniversary of the original grant date (May 3, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 197,727 RSUs until May 16, 2019. F4 · derivative.exercise_date: The Restricted Stock Units vest on the first anniversary of the date of grant. F4 · derivative.expiration_date: The Restricted Stock Units vest on the first anniversary of the date of grant. Read SEC document |
| May 16, 2019 Filed May 21, 2019 00:12 UTC | Option Care Health, Inc. BIOS · Entity 4126 | Disposition to issuerCommon Stock, $.0001 Par Value | 62,734 | $2.00 | $125,468.00 |
DisclosureSEC source: 0001127602-19-019235 · form4.xml · nonDerivative · entry 2 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,305 F3 · price: This transaction represents shares withheld by the Company for tax withholding on Mr. Greenleaf's settlement of the RSU award described in this Form 4 that was settled on May 16, 2019. Read SEC document |
| May 16, 2019 Filed May 21, 2019 00:12 UTC | Option Care Health, Inc. BIOS · Entity 4126 | Exercise / conversionCommon Stock, $.0001 Par Value | 197,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-019235 · form4.xml · nonDerivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,039 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: 197,727 Restricted Stock Units (RSUs) vested on the first anniversary of the original grant date (May 3, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 197,727 RSUs until May 16, 2019. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 17:33 UTC | Option Care Health, Inc. BIOS · Entity 4126 | Exercise / conversionRestricted Stock Unit · Derivative | 98,425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-015956 · form4.xml · derivative · entry 5 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,850 Underlying: Common Stock, $.0001 Par Value · 98,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F3 · date: One third (98,425 RSUs) of Mr. Greenleaf's original award of 295,275 RSUs vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 98,425 RSUs until April 18, 2019. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F7 · derivative.exercise_date: The remaining 196,850 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/2018). F7 · derivative.expiration_date: The remaining 196,850 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/2018). Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 17:33 UTC | Option Care Health, Inc. BIOS · Entity 4126 | Exercise / conversionRestricted Stock Unit · Derivative | 136,185 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-015956 · form4.xml · derivative · entry 4 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.0001 Par Value · 136,185 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels. F1 · date: 136,185 Restricted Stock Units (RSUs) vested in January 2019 based on the satisfaction of certain Company stock price trading targets; however, as provided in the grant agreement, the Company deferred settlement of the 136,185 RSUs until April 18, 2019 F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F5 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels. F6 · balance_after: Depending on Company stock price at the end of the performance period, payout may be 0, 50, 100 or 200% of reported amount. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 17:33 UTC | Option Care Health, Inc. BIOS · Entity 4126 | Disposition to issuerCommon Stock, $.0001 Par Value | 67,994 | $1.82 | $123,749.08 |
DisclosureSEC source: 0001127602-19-015956 · form4.xml · nonDerivative · entry 3 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,312 F4 · price: This transaction represents shares withheld by the Company for tax withholding on Mr. Greenleaf's settlement of the two RSU awards described in this Form 4 that were settled on April 18, 2019. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 17:33 UTC | Option Care Health, Inc. BIOS · Entity 4126 | Exercise / conversionCommon Stock, $.0001 Par Value | 98,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-015956 · form4.xml · nonDerivative · entry 2 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · date: One third (98,425 RSUs) of Mr. Greenleaf's original award of 295,275 RSUs vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 98,425 RSUs until April 18, 2019. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 17:33 UTC | Option Care Health, Inc. BIOS · Entity 4126 | Exercise / conversionCommon Stock, $.0001 Par Value | 136,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-015956 · form4.xml · nonDerivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: 136,185 Restricted Stock Units (RSUs) vested in January 2019 based on the satisfaction of certain Company stock price trading targets; however, as provided in the grant agreement, the Company deferred settlement of the 136,185 RSUs until April 18, 2019 F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 00:04 UTC | Option Care Health, Inc. BIOS · Entity 4126 | Exercise / conversionRestricted Stock Unit · Derivative | 64,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005479 · form4.xml · derivative · entry 3 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,700 Underlying: Common Stock, $.0001 Par Value · 64,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F1 · date: One third (64,350 RSUs) of Mr. Greenleaf's original award of 193,050 RSUs vested on the first anniversary of the original grant date (November 27, 2017); however, as provided in the grant agreement, the Company deferred settlement of the 64,350 RSUs until February 8, 2019. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F4 · derivative.exercise_date: The remaining 128,700 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (11/28/2017). F4 · derivative.expiration_date: The remaining 128,700 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (11/28/2017). Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 00:04 UTC | Option Care Health, Inc. BIOS · Entity 4126 | Tax withholdingCommon Stock, $.0001 Par Value | 21,654 | $3.59 | $77,737.86 |
DisclosureSEC source: 0001127602-19-005479 · form4.xml · nonDerivative · entry 2 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,696 F3 · price: This transaction represents shares withheld by the Company for tax withholding on Mr. Greenleaf's settlement of the 64,350 RSUs that vested on November 28, 2018. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 00:04 UTC | Option Care Health, Inc. BIOS · Entity 4126 | Exercise / conversionCommon Stock, $.0001 Par Value | 64,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005479 · form4.xml · nonDerivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: One third (64,350 RSUs) of Mr. Greenleaf's original award of 193,050 RSUs vested on the first anniversary of the original grant date (November 27, 2017); however, as provided in the grant agreement, the Company deferred settlement of the 64,350 RSUs until February 8, 2019. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 03, 2018 Filed May 7, 2018 20:01 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantRestricted Stock Unit · Derivative | 197,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016501 · form4.xml · derivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,727 Underlying: Common Stock, $.0001 Par Value · 197,727 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest on the first anniversary of the date of grant. F2 · derivative.expiration_date: The Restricted Stock Units vest on the first anniversary of the date of grant. Read SEC document |
| April 11, 2018 Filed Apr 13, 2018 21:00 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantRestricted Stock Unit · Derivative | 295,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-014571 · form4.xml · derivative · entry 2 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,275 Underlying: Common Stock, $.0001 Par Value · 295,275 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal installments commencing on the first anniversary of the date of grant. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal installments commencing on the first anniversary of the date of grant. Read SEC document |
| April 11, 2018 Filed Apr 13, 2018 21:00 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantEmployee Stock Option (Right to Buy) · Derivative | 228,421 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001127602-18-014571 · form4.xml · derivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,421 Underlying: Common Stock, $.0001 Par Value · 228,421 shares Expires 2028-04-11 F1 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant. Read SEC document |
| November 28, 2017 Filed Nov 30, 2017 21:01 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantRestricted Stock Unit · Derivative | 193,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-033533 · form4.xml · derivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,050 Underlying: Common Stock, $.0001 Par Value · 193,050 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in three equal installments commencing on the first anniversary of the date of grant. F2 · derivative.expiration_date: The Restricted Stock Units vest in three equal installments commencing on the first anniversary of the date of grant. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 20:58 UTC | Option Care Health, Inc. BIOS · Entity 4126 | PurchaseCommon Stock, $.0001 Par Value | 15,000 | $2.03 | $30,495.00 |
DisclosureSEC source: 0001127602-17-031889 · form4.xml · nonDerivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions in prices ranging from $2.033 to $2.04, inclusive. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 21:23 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantRestricted Stock Unit · Derivative | 136,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-005021 · form4.xml · derivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,185 Underlying: Common Stock, $.0001 Par Value · 136,185 shares Expires 2019-12-31 F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels. F2 · derivative.exercise_price: Depending on Company's stock price, as measured by 20-day average stock price ending December 31, 2019, payout may be 0, 50%, 100% or 200% of reported amount. F2 · shares: Depending on Company's stock price, as measured by 20-day average stock price ending December 31, 2019, payout may be 0, 50%, 100% or 200% of reported amount. F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 21:01 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantEmployee Stock Option (Right to Buy) · Derivative | 442,810 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001127602-16-069118 · form4.xml · derivative · entry 2 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,810 Underlying: Common Stock, $.0001 Par Value · 442,810 shares Expires 2023-12-01 F3 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 21:01 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantRestricted Stock Unit · Derivative | 377,358 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069118 · form4.xml · derivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,358 Underlying: Common Stock, $.0001 Par Value · 377,358 shares Expires 2020-12-31 F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest on December 31, 2020. Vested shares will be delivered to the reporting person on or before March 15, 2021. F2 · derivative.expiration_date: The Restricted Stock Units vest on December 31, 2020. Vested shares will be delivered to the reporting person on or before March 15, 2021. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 14:06 UTC | Option Care Health, Inc. BIOS · Entity 4126 | PurchaseCommon Stock, $.0001 Par Value | 16,000 | $1.30 | $20,784.00 |
DisclosureSEC source: 0001127602-16-066777 · form4.xml · nonDerivative · entry 1 GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 F1 · shares: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.